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previously shown age-related changes in mitochondrial
performance in perfused liver from rats at different stages
of development: weaning (24 days), adolescence (60
days), adulthood (180 days) and middle age (365 days).
In fact, we found that oxygen consumption, urea synthe-
sis, gluconeogenesis from lactate and ketone body pro-
duction decline with increasing age [5]. These im-
pairments occur at a relatively early life stage, and the
decrease in oxygen consumption could contribute to
enhancement of the rate of free radical production. The
rate of mitochondrial free radical generation seems to be
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Ageing is known to be associated with alterations in
various aspects of cell function. At the hepatic level,
ageing causes a decline in various metabolic pathways
[1]. The molecular basis of this decline is still not well
understood, but it seems that mitochondrial decay plays
an important role in the ageing process [2, 3]. Studies
using hepatocytes have shown an age-related decline in
mitochondrial membrane potential, respiratory control
ratios, and oxygen consumption [4]. In addition, we have
Abstract. The effect of treatment with acetyl-L-carnitine
on hepatic mitochondrial respiration and biosynthetic
function in perfused liver from young (90 days) and old
(22–24 months) rats was studied. Rats were given a 1.5%
(w/v) solution of acetyl-L-carnitine in their drinking wa-
ter for 1 month and oxygen consumption together with
the rate of gluconeogenesis, urea synthesis, and keto-
genesis with and without added substrates were measured
in perfused liver. Mitochondrial oxygen consumption was
also assessed in liver homogenate and isolated mitochon-
dria to determine the maximal capacity for oxidative
phosphorylation. Acetyl-L-carnitine treatment almost
completely restored the age-dependent decline in oxygen
consumption, gluconeogenesis, urea synthesis, and keto-
genesis found in perfused liver of old rats to the levels
found in young rats. In addition, acetyl-L-carnitine treat-
ment increased oxygen consumption and biosynthetic
function in perfused liver from young rats. After acetyl-
L-carnitine treatment, we found detectable 3-oxoacyl-
CoA-transferase activity associated with a consumption
of ketone bodies in young and old rats. Finally, oxygen
consumption measured in homogenate and isolated mito-
chondria did not change with age and acetyl-L-carnitine
treatment. Our results show that in perfused liver, acetyl-
L-carnitine treatment slows the age-associated decline in
mitochondrial respiration and biosynthetic function. In
addition, treatment of young rats with acetyl-L-carnitine
has a stimulating effect on liver metabolism, probably
through an increase in ATP production.
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dependent on the activity of the electron transport chain,
and it increases as complete reduction of oxygen is im-
paired [5].
Recent studies have shown that acetyl-L-carnitine
(ALCAR), a normal biomolecule [6] can slow the age-
related deficit in mitochondrial function in various tis-
sues [7, 8]. At the hepatic level, ALCAR was able to slow
the age-related decline in mitochondrial membrane
potential and cellular oxygen consumption found in
hepatocytes from old rats [9, 10].
In an attempt to gain insight into the ALCAR effects, we
decided to investigate whether the stimulatory effects of
ALCAR on hepatic mitochondrial respiration found in
old rats [10] also occur for other hepatic functional para-
meters. To this end, in the present study we assessed per-
fused liver oxygen consumption, stimulated by various
substrates, together with the rate of gluconeogenesis, urea
synthesis and ketogenesis in young (90 days) and old
(22–24 months) rats, whose diet was supplemented by
ALCAR. Mitochondrial respiration was also assessed in
liver homogenate and isolated mitochondria of these
above rats to determine if changes in this parameter due
to ageing and ALCAR treatment found in perfused liver
are associated with variation in maximal capacity for
oxidative phosphorylation.
Methods and Materials
Animals. Male Wistar rats bred in the animal house 
of Heinrich-Heine-University of Düsseldorf, were used
for the experiments. They were housed individually 
in grid-bottomed cages at 24 °C under an artificial cir-
cadian 12 h light/12 h dark cycle. At the start of the study,
24 rats were divided into four groups each composed of
6 rats, two groups aged 3 months (young rats) and the
remaining groups aged about 24 months (old rats). One
group of young and one of old rats, used as controls,
received ad libitum standard stock diet and water, while
the other two groups received ad libitum standard stock
diet and water supplemented with a 1.5% (w/v, pH
adjusted to 6) solution of ALCAR. The treatment period
lasted 1 month. At the end of the experimental period, the
rats were used for measurement of oxygen consumption,
gluconeogenesis, urea synthesis and ketogenesis in per-
fused liver. 
Another 32 male Wistar rats were divided into four
groups each composed of 8 rats. The age and the treat-
ment of these groups were the same as above. These rats
were used to determine oxygen consumption in liver
homogenates and isolated mitochondria, as well as for
measurement of 3-oxoacyl-CoA-transferase activity in
liver extracts. Animal care, housing and killing met the
guidelines of the European Community.
Liver perfusion. Perfusions were performed on livers
from 24-h-fasted rats since during 24-h fasting, liver
glycogen is reduced to a level that has been shown
previously to minimise glucose production via glycoge-
nolysis [11].
Rats were anaesthetised with sodium pentobarbital
(Nembutal; Sanofi, Bad Segeberg, Germany) by intra-
peritoneal injection of 12 mg/100 g body weight in iso-
tonic solution. Before opening the abdomen, heparin
(250 I.E./100 g) was injected into the femoral vein.
Livers were perfused in situ with Krebs-Henseleit bi-
carbonate buffer [12], pH 7.4, in a non-recirculating sys-
tem [13]. The fluid was pumped through a temperature-
regulated (37 °C) membrane oxygenator supplemented
with 95% O2/5% CO2, v/v, before entering the liver via a
cannula inserted into the portal vein. The arterial oxygen
concentration, maintained constant by the oxygenator,
was measured before and after each experiment. The
effluent perfusate was collected via a cannula placed in
the vena cava. It passed by a platinum electrode for con-
tinuous monitoring of the venous oxygen concentration,
and perfusate samples were collected every 1–2 min for
metabolite analyses. The flow rate was adjusted to the
metabolic activity of the liver as judged from the venous
oxygen concentration. From experiment to experiment it
varied between 5 and 6 ml min–1 g–1, but was constant in
each individual experiment. Substrates were added to the
perfusion fluid before entering the liver. The final con-
centrations of substrates were: b-hydroxybutyrate 0.5
mM + acetoacetate 0.5 mM, lactate + pyruvate 2 mM at a
ratio lactate/pyruvate of 7, glycerol 12 mM, NH4HCO3
1.2 mM, hexanoate 0.5 mM, palmitate 0.5 mM. Palmitate
was dissolved in a bovine serum albumin solution: 1 g
palmitate was slowly added to 170 ml albumin solution
(20 g/100 ml) under gentle stirring which was continued
for a further 2 h at room temperature.
Before addition of the substrates, the liver was perfused
for 10–15 min until a steady state was reached, i.e. the
oxygen consumption rate remained constant. Following
the addition of each substrate, the liver was allowed to
reach steady state before further additions (ca 10–15
min). 
After termination of the perfusion, the wet weight of the
liver was determined.
Metabolic rates. Glucose, ammonia, urea, lactate, pyru-
vate, b-hydroxybutyrate and acetoacetate concentrations
were measured in perchloric acid extracts of the perfusate
samples using enzymatic analysis by spectrophotometric
procedures coupled to the appearance or disappearance
of NADH [14]. The steady-state metabolic rates were cal-
culated from the arteriovenous concentration differences
of oxygen, glucose, urea, b-hydroxybutyrate and ace-
toacetate, the flow rate, and the liver wet weight.
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Preparation of liver homogenates and isolated mito-
chondria. After 24 h fasting, rats were anaesthetised by
an intraperitoneal injection of choral hydrate (400 mg/kg
body weight) and livers were collected. After removal of
the liver, small samples (2 g) were taken for preparation
of tissue extracts and immediately frozen in liquid nitro-
gen. The remainder of the tissue was finely minced and
washed with a medium containing 220 mM mannitol,
70 mM sucrose, 20 mM Tris, pH 7.4, 1 mM EDTA, and
0.1% (w/v) fatty-acid-free bovine serum albumin. Tissue
fragments were gently homogenised with the same
medium (1:4, w/v) in a Potter Elvehjem homogeniser set
at 500 rpm (4 strokes/min) and filtered through sterile
gauze. Aliquots of the homogenate were then used to
determine respiratory activities, while the remaining
homogenate was further processed to prepare isolated
mitochondria. Homogenate was freed of nuclei by centri-
fugation at 1000 gav for 10 min; the resulting supernatant
was centrifuged at 3000 gav for 10 min. The mitochondrial
pellet was washed twice and finally resuspended in a sus-
pension medium containing 80 mM KCl, 50 mM Hepes,
pH 7.0, 5 mM KH2PO4, 1 mM EGTA, 0.1% (w/v) fatty-
acid-free bovine serum albumin. The protein content of
the mitochondrial suspension was determined by the
method of Hartree [15] using bovine serum albumin as
the protein standard.
Measurement of respiration in liver homogenates and
mitochondria. Maximal oxygen consumption rates were
measured in homogenates and isolated mitochondria
polarographically with a Clark-type electrode (Yellow
Springs Instruments, Yellow Springs, Ohio), maintained
in a water-jacketed chamber at 30 °C, as previously
reported [16]. Briefly, aliquots of homogenates and iso-
lated mitochondria were incubated in 3 ml of the above
suspension medium and were allowed to oxidise their
endogenous substrates for a few minutes. Substrates were
then added at the following concentration: 40 mM pal-
mitoylcarnitine + 2.5 mM malate, 40 mM palmitoylco-
enzyme A + 2 mM carnitine + 2.5mM malate. Measure-
ments were performed in the presence of 0.6 mM ADP.
Determination of 3-oxo acyl CoA-transferase activity.
The determination of the rate of acetoacetyl-CoA forma-
tion from succinyl-CoA and acetoacetate was made in
liver extracts according to Williamson et al. [17]. Briefly,
samples of frozen liver were finely minced and ho-
mogenised (1:4 w/v) with a medium containing 0.25 M
sucrose, 1 mM 2-mercaptoethanol, 10 mM Tris, pH 7.4,
in a Potter-Elvehjem homogeniser. The homogenate was
immediately exposed to ultrasonic vibration for exactly
30 s at 15 kHz (100 W). The ultrasonically treated ho-
mogenate was then centrifuged for 20 min at 30000 gav .
The supernatant fluid was considered to contain the total
soluble protein of the cell (i.e. cytoplasm and mitochon-
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Figure 1. Effect of ALCAR treatment on oxygen consumption
measured in perfused liver of young and old rats in the absence of
substrates (A), in the presence of lactate + pyruvate (L + P) as
substrates (B), in the presence of glycerol as substrate (C); or in the
presence of lactate + pyruvate + NH4HCO3 (L + P + N) as substrates
(D). Statistical difference by ANOVA (P < 0.05): # effect of age,
* effect of ALCAR treatment.
drial matrix) and its enzyme activity is referred to in the
text as the tissue activity. Enzyme activity was measured
at 25 °C in a medium containing 50 mM Tris, pH 8.5,
5 mM MgCl, 5 mM Iodoacetamide, 0.1 mM succinyl-CoA,
and 1 mM acetoacetate.
Statistical analysis. Data are given as means ± SEM of
different rats. Statistical analyses were performed by two-
tailed unpaired Student’s t test or two-way analysis of vari-
ance (ANOVA) for the main effects of age and ALCAR
treatment as well as for the interaction effect between age
and ALCAR treatment. Probability values less than 0.05
were considered to indicate a significant difference. All
analyses were performed using GraphPad Prism (Graph-
Pad Software, San Diego, Calif.).
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Figure 2. Effect of ALCAR treatment on oxygen consumption
measured in perfused liver of young and old rats in the presence of
b-hydroxybutyrate + acetoacetate (B + A) as substrates (A), in the
presence of hexanoate as substrate (B), or in the presence of palmi-
tate as substrate (C). Statistical difference by ANOVA (P < 0.05):
# effect of age, * effect of ALCAR treatment.
Figure 3. Effect of ALCAR treatment on gluconeogenesis measu-
red in perfused liver of young and old rats in the absence of sub-
strates (A), in the presence of Lactate + Pyruvate (L + P) as
substrates (B), or in the presence of glycerol as substrate (C).
Statistical difference by ANOVA (P < 0.05): # effect of age, * effect
of ALCAR treatment.
Materials. b-Hydroxybutyrate, acetoacetate, lactate, py-
ruvate, NH4HCO3, hexanoate, palmitate, glycerol, b-
hydroxybutyrate dehydrogenase, NAD, NADH, ATP,
ADP, NADP, lactate dehydrogenase, glucose-6-phosphate
dehydrogenase, hexokinase, glutamate dehydrogenase,
urease, iodoacetamide, succinyl-CoA ADP, malate,
palmitoylcarnitine, carnitine, palmitoylCoA, and fatty-
acid-free bovine serum albumin were from Boehringer
(Mannheim, Germany) or Sigma (Munich, Germany).
Other chemicals were from Merck (Darmstadt, Germany).
All reagents were of the highest commercially available
purity.
Results
Livers were perfused in situ in the absence of exogenous
substrates and basal oxygen consumption was measured
(fig. 1A). The results show a significant decline in hepat-
ic oxygen consumption with age, while treatment with
ALCAR significantly increased basal oxygen consump-
tion in both young and old rats. We also measured oxygen
consumption in the presence of various substrates. The
addition of a substrate to perfused liver caused a rapid
(less than 1 min) increase in oxygen consumption (figs
1B–D, 2). Whatever the substrate, oxygen consumption
was significantly lower in old compared to young rats,
while it significantly increased in young and old
ALCAR-treated rats compared to their respective con-
trols. 
Gluconeogenesis was measured both without substrates
and following addition of lactate + pyruvate or glycerol,
in the presence of 1 mM hydroxybutyrate + acetoacetate
to saturate respiration (fig. 3A–C). Hydroxybutyrate +
acetoacetate did not interfere with gluconeogenesis; in
fact, the addition of hydroxybutyrate + acetoacetate to
Krebs-Henseleit buffer was without effect on gluconeo-
genesis (not shown). Gluconeogenesis with lactate +
pyruvate or glycerol significantly decreased with age and
significantly increased in ALCAR-treated rats compared
to their respective controls, whereas basal gluconeogene-
sis did not significantly change with age and significantly
increased in ALCAR-treated rats compared to their
respective controls.
The rate of urea synthesis in the absence of exogenous
substrates is shown in figure 4A. It did not change with
age, while treatment with ALCAR significantly increased
the rate of urea synthesis in both young and old rats. For
a reasonably high rate of urea synthesis, a nitrogen source
must be added together with a precursor for oxalacetate.
Therefore, ammonia and lactate + pyruvate were added to
prevent a possible shortage of intermediates and energy.
In this condition, the production of urea decreased with
age and significantly increased in ALCAR-treated rats
compared to their respective controls (fig. 4B).
The rate of ketogenesis and the hydroxybutyrate/aceto-
acetate ratio with and without added substrate are report-
ed in table 1. The rate of ketogenesis in the absence of
substrate did not change with age or ALCAR treatment.
The hydroxybutyrate/acetoacetate ratio significantly in-
creased in old compared to young rats and significantly
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Figure 4. Effect of ALCAR treatment on urea synthesis measured
in perfused liver of young and old rats in the absence of substrates
(A), or in the presence of lactate + pyruvate + NH4HCO3 (L + P +
N) as substrates (B). Statistical difference by ANOVA (P < 0.05):
# effect of age, * effect of ALCAR treatment.
Table 1. Effect of ALCAR treatment on ketogenesis and the b-hydroxybutyrate/acetoacetate (B/A) ratio measured in perfused livers of
young and old rats.
Addition Young Young + ALCAR Old Old + ALCAR ANOVA
main effect main effect interaction
of age of ALCAR
treatment
None
A + B 26.0 ± 1.1 30.0 ± 1.9 29.0 ± 0.7 31.0 ± 2.0 NS NS NS
B/A 0.24 ± 0.02 0.25 ± 0.02 0.34 ± 0.01 0.26 ± 0.012 <0.05 <0.05 <0.05
Hexanoate
A + B 139.0 ± 0.8 163.0 ± 0.7 108.0 ± 4.3 140.0 ± 1.0 <0.0001 <0.0001 NS
B/A 0.99 ± 0.01 2.0 ± 0.1 2.0 ± 0.1 2.95 ± 0.034 <0.0001 <0.0001 NS
Palmitate
A+B 55.0 ± 0.8 96.0 ± 3.6 68.0 ± 2.8 93.0 ± 6.4 NS <0.0001 NS
B/A 0.49 ± 0.01 2.28 ± 0.12 2.25 ± 0.13 3.8 ± 0.1 <0.0001 <0.0001 NS
Values are reported as mean ± SE of six experiments [mmol/h ¥ g wet liver)]. NS, not significant.
decreased only in old rats after ALCAR treatment. With
hexanoate added, ketone body production declined with
age and increased after ALCAR treatment. With pal-
mitate, ketone body production increased after ALCAR
treatment, while no variation due to age was observed.
With both fatty acids, the redox hydroxybutyrate/aceto-
acetate ratio significantly increased in old compared to
young rats and after ALCAR treatment.
Table 2 reports hepatic ketone body consumption rate and
3-oxoacyl-CoA-transferase activity, the enzyme which
catalyses the rate-limiting step of ketone body degrada-
tion. The results show the presence of ketone body con-
sumption and 3-oxoacyl-CoA-transferase activity only
after ALCAR treatment, with significantly lower values
in old compared to young rats.
Table 3 shows no variation in maximal respiratory rates
of homogenate and isolated mitochondria using palmi-
toylCoA + malate or palmitoylcarnitine + malate as the
substrate.
Discussion
In this work we studied the effect of ALCAR administra-
tion on liver metabolism in young and old rats. This
natural biomolecule, when administered orally, is ab-
sorbed in the jejunum by simple diffusion and Na+-de-
pendent active transport [18]. In addition, ALCAR is
deacetylated during or immediately after uptake into in-
testinal cells and a portion of the newly formed intracel-
lular free carnitine is apparently reacetylated [19]. There-
fore, use of ALCAR as a dietary supplement could be
equivalent to that of L-carnitine. However, at least in
some metabolic pathways [20–22], ALCAR seems to be
the metabolically active molecule. 
Our present results show that ALCAR treatment in both
young and old rats significantly increases oxygen con-
sumption, urea synthesis, gluconeogenesis and ketone
body production, all assessed in perfused liver. In addition,
since oxygen consumption and the above-mentioned bio-
synthetic functions are reduced in old compared to young
rats, treatment of old rats with ALCAR almost completely
restores them to the levels found in young rats.
The decrease in oxygen consumption without added
substrates found in old rats suggests a decline in NADH
oxidation. In fact, there is a concomitant increase in the
hydroxybutyrate/acetoacetate ratio, measured in the
effluent perfusate as an index of the mitochondrial
NADH/NAD ratio [23]. The reduced NADH oxidation is
probably due to lower energy requirements and not im-
pairment of respiratory chain activity; in fact, maximal
oxidative capacity measured in homogenate and isolated
mitochondria did not vary. ALCAR treatment signifi-
cantly increased oxygen consumption in young and old
rats. This finding is in agreement with the results ob-
tained by Hagen et al. [10], who found in isolated hepato-
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Table 2. Effect of ALCAR treatment on ketone body consumption
rate and 3-oxoacyl-CoA-transferase activity measured in livers of
young and old rats.
Young Young + Old Old +
ALCAR ALCAR
Ketone body con- – 28.0 ± 1 – 15.0 ± 1*
sumption [mmol/ 
(h ¥ g wet liver)]
3-Oxoacyl-CoA-
transferase nmol/
[(min ¥ g wet liver)] – 62.7 ± 3.2 – 29.8 ± 5.0*
Values are reported as mean ± SE of six experiments (– undetectable).
* P < 0.05 compared to young + ALCAR (two-tailed Student’s 
t-test).
Table 3. Effect of ALCAR treatment on oxygen consumption measured in liver homogenate and isolated mitochondria of young and 
old rats.
Young Young + Old Old + ANOVA
ALCAR ALCAR
main effect main effect inter-
of age of ALCAR action
treatment
Isolated mitochondria [nmol O/(min ¥ mg protein)]
Palmitoyl CoA + malate 95.4 ± 6.0 91 ± 7 102  ± 7 107 ± 8 NS NS NS
Palmitoylcarnitine + malate 92.8 ± 8 86 ± 7 99.7 ± 7 110 ± 10 NS NS NS
Homogenate nmol O/(min ¥ g wet liver)
Palmitoyl CoA + malate 4601 ± 96 4157 ± 295 4897 ± 200 4776 ± 446 NS NS NS
Palmitoylcarnitine + malate 4459 ± 107 4898 ± 110 5427 ± 277 4761 ± 402 NS NS NS
Values are reported as mean ± SEM of eight experiments. NS, not significant.
cytes an increase in oxygen consumption after ALCAR
treatment in old rats. These authors, however, did not
report data on the effect of ALCAR treatment on young
rats. Moreover, the increase in the hydroxybutyrate/
acetoacetate ratio found in old compared to young rats is
almost completely suppressed by ALCAR treatment, sug-
gesting an increase in NADH oxidation. 
We also measured oxygen consumption and the rate of
ketogenesis in perfused livers in the presence of a lipid
substrate, namely palmitate or hexanoate. Palmitate oxi-
dation involves acylcarnitine formation and transloca-
tion, while that of hexanoate does not. Ketogenesis from
hexanoate and oxygen consumption with hexanoate or
palmitate was significantly decreased in old compared to
young rats. In addition, ALCAR treatment increased
ketogenesis and oxygen consumption whatever the sub-
strate, both in young and old rats. As for ketogenesis, the
greater effect of ALCAR treatment was on ketogenesis
from palmitate in young rats (+74%). Part of this in-
crease is conceivably due to an increased activity of
carnitine-acylcarnitine exchange across the inner mito-
chondrial membrane, which is of great importance for
oxidation of long-chain fatty acids. In addition, since the
activity of the carnitine acyltransferase system controls
the rate of fatty acid oxidation [6], it may be responsible
for the age-related decrease in oxygen consumption that
we observed. In agreement, studies on mitochondria indi-
cate that the activity of this exchange reaction decreases
significantly with age [24]. The lower intramitochondrial
pool of carnitine has been suggested to be in part respon-
sible for this age effect [25], and ALCAR treatment slows
the age-related decrease in the level of the intramitochon-
drial pool of carnitine [25]. To gain further insight into
the mechanism of increased oxygen consumption found
after ALCAR treatment, we measured oxygen consump-
tion using as substrate palmitoylcarnitine or palmitoyl-
CoA in isolated mitochondria, to obtain direct informa-
tion on maximal oxidative capacity. To link this param-
eter with the effective mitochondrial protein mass, oxygen
consumption was also measured in the homogenate. The
results indicate that there was no variation in oxidative
capacity in either mitochondria or homogenate. There-
fore, the increased oxygen consumption found in per-
fused liver after ALCAR treatment is possibly due to an
increase in the activity of acyl-CoA-synthetase, the
enzyme which catalyses the activation of fatty acids to
acyl-CoA esters, rather than to an increase in maximal
oxidative capacity. In agreement, an increase in the
hydroxybutyrate/acetoacetate ratio was found after
ALCAR treatment. Thus, ALCAR could stimulate liver
metabolic activity, increasing liver ATP production,
which is consistent with the increase in hepatic gluco-
neogenesis and urea synthesis that we found.
An interesting result was obtained when the livers were
perfused with hydroxybutyrate + acetoacetate. The ob-
served increase in oxygen consumption obtained with
these substrates should only be due to an increase in
NADH production coming from hydroxybutyrate oxida-
tion to acetoacetate, since the liver is generally accepted
as unable to utilise ketone bodies as substrates [17, 26].
However, we found consumption of ketone bodies in
young and old rats after ALCAR treatment, indicating
that in these rats, ketone bodies are converted back
acetyl-CoA. This would suggest that, in young and old
rats after ALCAR treatment, the enzyme which catalyses
the rate-limiting step of ketone body degradation, 3-
oxoacyl-CoA-transferase, is present. This result is quite
unexpected: only foetal [27] and weaning liver [5] are
known to be able to oxidise ketones, while 3-oxoacyl-
CoA-transferase is not present in the liver of adult rats
[17, 26]. The absence of 3-oxoacyl-CoA-transferase in
liver mitochondria has been taken as evidence for many
years that the liver cannot utilise ketone bodies. This con-
cept should be revised in the light of our results demon-
strating this enzyme in young and old rats after ALCAR
treatment. In these rats, the role of 3-oxoacyl-CoA-trans-
ferase may be to produce a substrate cycle between
acetoacetyl-CoA and acetoacetate with a consequent
wastage of energy. Another implication of the presence of
3-oxoacyl-CoA-transferase in rat liver after ALCAR sup-
plementation is to reduce the high rate of ketogenesis by
removal of acetoacetate and by inhibition of flux through
the HMG-CoA-synthase reaction [28]. In fact, the rate of
ketogenesis in isolated mitochondria is very sensitive to
the physiological concentration of acetoacetyl-CoA [29].
Using liver perfusion, we measured the rate of bio-
chemical pathways like gluconeogenesis and urea synthe-
sis and their respective oxygen consumptions. Gluconeo-
genesis was measured in presence of lactate + pyruvate or
glycerol. Gluconeogenesis from lactate +pyruvate in-
volves mitochondria, whereas that from glycerol does
not. Despite the utilisation of different metabolic path-
ways by the two substrates, gluconeogenesis and oxygen
consumption fell in old compared to young rats. The last
result is partially in agreement with Sastre et al. [1] who
found, in isolated hepatocytes, a decrease with age only in
gluconeogenesis from lactate + pyruvate. Age-related
declines in the activity of phosphoenolpyruvate carboxy-
kinase [30, 31], considered the rate-limiting enzyme of
gluconeogenesis from lactate [1], are consistent with our
results. Moreover, we found that ALCAR treatment in-
creased gluconeogenesis in both old and young rats. The
effect of ALCAR on gluconeogenesis from lactate + py-
ruvate could be explained as follows. The lower rate of
gluconeogenesis from lactate + pyruvate has been re-
ported as due to an impaired transport of malate across
the mitochondrial membrane using the dicarboxylate car-
rier [1] and this impairment is associated with a con-
comitant decrease in mitochondrial cardiolipin content
[25]. Therefore, ALCAR treatment, by increasing the
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cardiolipin concentration [25], would positively in-
fluence the activity of protein carriers. 
Urea synthesis, an exclusive biosynthetic function of the
liver, decreased with age; ALCAR treatment reversed this
effect and increased the urea synthesis rate in young rats,
probably due to its stimulating effect on ATP production. 
The results of this work clearly demonstrate that in per-
fused liver, ALCAR treatment has a stimulating effect 
on metabolism. ALCAR treatment can slow some cel-
lular metabolic dysfunctions due to age, probably
through maintenance of mitochondrial function. 
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